These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 7518927
1. Prolactin activates the interferon-regulated p91 transcription factor and the Jak2 kinase by tyrosine phosphorylation. David M, Petricoin EF, Igarashi K, Feldman GM, Finbloom DS, Larner AC. Proc Natl Acad Sci U S A; 1994 Jul 19; 91(15):7174-8. PubMed ID: 7518927 [Abstract] [Full Text] [Related]
2. Ethanol inhibits prolactin-induced activation of the JAK/STAT pathway in cultured astrocytes. DeVito WJ, Stone S. J Cell Biochem; 1999 Aug 01; 74(2):278-91. PubMed ID: 10404396 [Abstract] [Full Text] [Related]
3. IgG immune complexes inhibit IFN-gamma-induced transcription of the Fc gamma RI gene in human monocytes by preventing the tyrosine phosphorylation of the p91 (Stat1) transcription factor. Feldman GM, Chuang EJ, Finbloom DS. J Immunol; 1995 Jan 01; 154(1):318-25. PubMed ID: 7995951 [Abstract] [Full Text] [Related]
4. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells. Schaber JD, Fang H, Xu J, Grimley PM, Rui H. Cancer Res; 1998 May 01; 58(9):1914-9. PubMed ID: 9581833 [Abstract] [Full Text] [Related]
5. JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription. Han Y, Watling D, Rogers NC, Stark GR. Mol Endocrinol; 1997 Jul 01; 11(8):1180-8. PubMed ID: 9212064 [Abstract] [Full Text] [Related]
6. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase. Frasor J, Barkai U, Zhong L, Fazleabas AT, Gibori G. Mol Endocrinol; 2001 Nov 01; 15(11):1941-52. PubMed ID: 11682625 [Abstract] [Full Text] [Related]
8. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription. Ferrag F, Chiarenza A, Goffin V, Kelly PA. Mol Endocrinol; 1996 Apr 01; 10(4):451-60. PubMed ID: 8721989 [Abstract] [Full Text] [Related]
9. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription. Berchtold S, Volarevic S, Moriggl R, Mercep M, Groner B. Mol Endocrinol; 1998 Apr 01; 12(4):556-67. PubMed ID: 9544991 [Abstract] [Full Text] [Related]
10. Characterization of a rat uterine cell line, U(III) cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor beta, alpha(2)-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway. Prigent-Tessier A, Barkai U, Tessier C, Cohen H, Gibori G. Endocrinology; 2001 Mar 01; 142(3):1242-50. PubMed ID: 11181541 [Abstract] [Full Text] [Related]
11. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin. Jabbour HN, Critchley HO, Boddy SC. J Clin Endocrinol Metab; 1998 Jul 01; 83(7):2545-53. PubMed ID: 9661641 [Abstract] [Full Text] [Related]
12. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes. Dogusan Z, Hooghe R, Verdood P, Hooghe-Peters EL. J Neuroimmunol; 2001 Nov 01; 120(1-2):58-66. PubMed ID: 11694320 [Abstract] [Full Text] [Related]
13. Differential tyrosine phosphorylation of JAK1, JAK2, and STAT1 by growth hormone and interferon-gamma in IM-9 cells. Silva CM, Lu H, Weber MJ, Thorner MO. J Biol Chem; 1994 Nov 04; 269(44):27532-9. PubMed ID: 7525556 [Abstract] [Full Text] [Related]
14. Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Campbell GS, Argetsinger LS, Ihle JN, Kelly PA, Rillema JA, Carter-Su C. Proc Natl Acad Sci U S A; 1994 Jun 07; 91(12):5232-6. PubMed ID: 7515493 [Abstract] [Full Text] [Related]
15. Unexpected transcriptional signals in normal and mitotically defective cells mediated through cytokine and growth factor receptors. Samanta A, Qian X, Greene MI. DNA Cell Biol; 1995 Nov 07; 14(11):921-30. PubMed ID: 7576178 [Abstract] [Full Text] [Related]
16. Receptor to nucleus signaling by prolactin and interleukin 2 via activation of latent DNA-binding factors. Gilmour KC, Reich NC. Proc Natl Acad Sci U S A; 1994 Jul 19; 91(15):6850-4. PubMed ID: 8041708 [Abstract] [Full Text] [Related]
17. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor. Dif F, Saunier E, Demeneix B, Kelly PA, Edery M. Endocrinology; 2001 Dec 19; 142(12):5286-93. PubMed ID: 11713228 [Abstract] [Full Text] [Related]
18. Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid. Rui H, Xu J, Mehta S, Fang H, Williams J, Dong F, Grimley PM. J Biol Chem; 1998 Jan 02; 273(1):28-32. PubMed ID: 9417042 [Abstract] [Full Text] [Related]
19. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation. Endo T, Sasaki A, Minoguchi M, Joo A, Yoshimura A. J Biochem; 2003 Jan 02; 133(1):109-13. PubMed ID: 12761205 [Abstract] [Full Text] [Related]
20. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter. Selvaraj NG, Omi E, Gibori G, Rao MC. Mol Endocrinol; 2000 Dec 02; 14(12):2054-65. PubMed ID: 11117534 [Abstract] [Full Text] [Related] Page: [Next] [New Search]